Physician
Navarro Pain Control Group INC.
Navarro Pain Control Group INC. was paid $4.11M by Medicaid between Jan 2018 and Dec 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoNAVARRO PAIN CONTROL GROUP INC.
CHULA VISTA, CA 91914
CHULA VISTA, CA 91914
33aNPI1265727762assigned 06/13/2011
33bProvider typeInterventional Pain Medicine Physician
28Total paid$4.11M
24GClaims79,052
24DCodes billed47
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in California
Rank by total paid#2 of 47
Median peer was paid$9K
This provider vs. median455×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,480 | $579K | |
| 2019 | 14,407 | $631K | |
| 2020 | 12,905 | $590K | |
| 2021 | 11,019 | $613K | |
| 2022 | 10,983 | $617K | |
| 2023 | 9,739 | $580K | |
| 2024incomplete | 7,519 | $498K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 18,300 | 17,271 | $1.18M |
| 62323 | 24% | 4,352 | 4,049 | $966K | |
| 76942 | 7.7% | 5,998 | 5,175 | $318K | |
| 64493 | 6.9% | 1,802 | 1,482 | $281K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.4% | 2,488 | 2,484 | $223K |
| 20552 | 4.6% | 3,677 | 3,253 | $190K | |
| 64494 | 3.4% | 1,798 | 1,476 | $138K | |
| 64490 | 2.7% | 630 | 502 | $110K | |
| 64495 | 2.6% | 1,346 | 1,092 | $106K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 1,297 | 1,259 | $87K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 805 | 792 | $76K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1.6% | 9,249 | 8,142 | $65K |
35 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 1,276 | $63K |
| 64491 | 1.3% | 628 | $52K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 1,128 | $44K |
| 64492 | <1% | 428 | $38K | |
| 64635 | <1% | 73 | $26K | |
| 64636 | <1% | 73 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,141 | $18K |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | <1% | 5,444 | $14K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 70 | $9K |
| 62321 | <1% | 28 | $7K | |
| 64633 | <1% | 14 | $6K | |
| 20611 | <1% | 81 | $6K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,203 | $6K |
| 64634 | <1% | 14 | $6K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,776 | $5K |
| 99152 | <1% | 96 | $5K | |
| 23350 | <1% | 34 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,388 | $4K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 6,078 | $4K |
| 20550 | <1% | 118 | $4K | |
| 95970 | <1% | 101 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 135 | $3K |
| 99153 | Mod sedat endo service >5yrs | <1% | 94 | $3K |
| 27369 | <1% | 16 | $2K | |
| 95971 | <1% | 46 | $2K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 23 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 745 | $1K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,161 | $1K |
| 99442 | <1% | 15 | $1K | |
| 20553 | <1% | 16 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 40 | $863.12 |
| J3490 | Unclassified drugs | <1% | 78 | $726.65 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 278 | $245.70 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,053 | $185.71 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 418 | $127.15 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNAVARRO, ROSA (PRESIDENT / OWNER)